(Q36060419)

11 August 2017

An E3 ubiquitin ligase: c-Cbl: a new therapeutic target of lung cancer (English)

1 reference

11 August 2017

1 reference

4

Ravi Salgia

1 reference

11 August 2017

Fang-Yi Lo

1

1 reference

11 August 2017

Yi-Hung Carol Tan

series ordinal

2

1 reference

11 August 2017

Hung-Chi Cheng

series ordinal

3

1 reference

11 August 2017

Yi-Ching Wang

series ordinal

5

1 reference

11 August 2017

language of work or name

English

0 references

publication date

23 May 2011

1 reference

11 August 2017

1 reference

11 August 2017

117

1 reference

11 August 2017

23

1 reference

11 August 2017

5344-5350

1 reference

Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383858

CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383858

The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383858

Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383858

A tale of two Cbls: interplay of c-Cbl and Cbl-b in epidermal growth factor receptor downregulation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383858

Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383858

The Cbl family proteins: ring leaders in regulation of cell signaling

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383858

A Novel Consensus Motif in Fibronectin Mediates Dipeptidyl Peptidase IV Adhesion and Metastasis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383858

Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383858

The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383858

Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383858

EGFR mutants found in non-small cell lung cancer show different levels of sensitivity to suppression of Src: implications in targeting therapy.

11 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.26153

Flt3-dependent transformation by inactivating c-Cbl mutations in AML

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.26153

21 January 2018

Identifiers

DOI

10.1002/CNCR.26153

1 reference

release_bz56nfi5xfehrnrfi3hilnsoqq

11 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bz56nfi5xfehrnrfi3hilnsoqq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

11 August 2017

PubMed publication ID

21607942

1 reference